The present disclosure relates to compounds effective as human protein
tyrosine phosphatase beta (HPTP-.beta.) inhibitors thereby regulating
angiogenesis. The present disclosure further relates to compositions
comprising one or more human protein tyrosine phosphatase beta
(HPTP-.beta.) inhibitors, and to methods for regulating angiogenesis.